Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Remimazolam and Emergence Delirium in Pediatrics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on remimazolam and emergence delirium in pediatric patients undergoing neurosurgery; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)
  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Peking University First Hospital | Conditions: Pediatric, Neurosurgery | Phase 4 | Status: RECRUITING